Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Cosmos Pharmaceutical Corp (3349)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14,570.0 +15.0    +0.10%
06:59:56 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 102,200
  • Bid/Ask: 14,560.0 / 14,575.0
  • Day's Range: 14,440.0 - 14,580.0
Type:  Equity
Market:  Japan
ISIN:  JP3298400007 
Cosmos Pharmaceutical Corp 14,570.0 +15.0 +0.10%

3349 Balance Sheet

 
Assess the latest Cosmos Pharmaceutical Corp balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 3349 Annual Report data, financial summaries and charts are available for Cosmos Pharmaceutical Corp investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
29/02
2023
30/11
2023
31/08
2023
31/05
Total Current Assets 116319 132059 141751 137085
Cash and Short Term Investments 18450 29696 45916 45928
Cash - - - -
Cash & Equivalents 18450 29696 45916 45928
Short Term Investments - - - -
Total Receivables, Net 567 520 493 10221
Accounts Receivables - Trade, Net 567 520 493 452
Total Inventory 82511 85315 79829 77479
Prepaid Expenses - - - 2429
Other Current Assets, Total 14791 16528 15513 1028
Total Assets 430241 436155 435129 420967
Property/Plant/Equipment, Total - Net 288190 278601 268772 259464
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 480 511 513 547
Long Term Investments 25251 24983 24092 21601
Note Receivable - Long Term - - - 9769
Other Long Term Assets, Total 1 1 1 2
Other Assets, Total 96735 101323 94849 70554
Total Current Liabilities 189545 198289 202445 192053
Accounts Payable 160289 167050 172982 161852
Payable/Accrued - - - -
Accrued Expenses - - - 7272
Notes Payable/Short Term Debt - - - 2741
Current Port. of LT Debt/Capital Leases 2741 2741 2741 1744
Other Current liabilities, Total 26515 28498 26722 18444
Total Liabilities 205961 215266 219828 209896
Total Long Term Debt 7962 8648 9333 13716
Long Term Debt 7962 8648 9333 10018
Capital Lease Obligations - - - 3698
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 8454 -3060 8050 -11373
Total Equity 224280 220889 215301 211071
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 4178 4178 4178 4178
Additional Paid-In Capital 5101 5101 4610 4610
Retained Earnings (Accumulated Deficit) 215188 211795 206716 202485
Treasury Stock - Common -224 -224 -242 -242
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 37 39 39 40
Total Liabilities & Shareholders' Equity 430241 436155 435129 420967
Total Common Shares Outstanding 39.63 39.63 39.6 39.6
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

3349 Price Commentary

Write your thoughts about Cosmos Pharmaceutical Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email